SEMHF Stock - Siemens Healthineers AG
Unlock GoAI Insights for SEMHF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $27.43B | $22.36B | $21.68B | $21.71B | $18.00B |
| Gross Profit | $10.60B | $8.47B | $7.71B | $8.14B | $6.95B |
| Gross Margin | 38.6% | 37.9% | 35.6% | 37.5% | 38.6% |
| Operating Income | $4.03B | $3.30B | $2.44B | $3.06B | $2.78B |
| Net Income | $2.52B | $1.94B | $1.51B | $2.04B | $1.73B |
| Net Margin | 9.2% | 8.7% | 7.0% | 9.4% | 9.6% |
| EPS | $2.25 | $1.74 | $1.35 | $1.82 | $1.57 |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Visit WebsiteEarnings History & Surprises
SEMHFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | — | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.81 | $0.72 | -10.4% | ✗ MISS |
Q3 2025 | Jul 30, 2025 | $0.63 | $0.58 | -7.7% | ✗ MISS |
Q2 2025 | May 5, 2025 | $0.61 | $0.52 | -16.0% | ✗ MISS |
Q1 2025 | Feb 6, 2025 | $0.49 | $0.43 | -10.8% | ✗ MISS |
Q4 2024 | Nov 6, 2024 | $0.71 | $0.60 | -15.5% | ✗ MISS |
Q3 2024 | Jul 31, 2024 | $0.55 | $0.45 | -18.3% | ✗ MISS |
Q2 2024 | May 7, 2024 | $0.55 | $0.41 | -26.1% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | $0.49 | $0.42 | -14.5% | ✗ MISS |
Q3 2023 | Sep 30, 2023 | $0.62 | $0.51 | -18.0% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | $0.55 | $0.43 | -21.0% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $0.46 | $0.10 | -77.9% | ✗ MISS |
Q1 2023 | Feb 2, 2023 | $0.47 | $0.51 | +9.3% | ✓ BEAT |
Q4 2022 | Nov 9, 2022 | $0.61 | $0.66 | +8.3% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $0.50 | $0.44 | -12.2% | ✗ MISS |
Q2 2022 | May 4, 2022 | $0.62 | $0.71 | +13.5% | ✓ BEAT |
Q1 2022 | Feb 3, 2022 | $0.58 | $0.63 | +7.7% | ✓ BEAT |
Q4 2021 | Nov 8, 2021 | $0.63 | $0.61 | -3.6% | ✗ MISS |
Q3 2021 | Jul 30, 2021 | $0.53 | $0.66 | +24.3% | ✓ BEAT |
Latest News
Frequently Asked Questions about SEMHF
What is SEMHF's current stock price?
What is the analyst price target for SEMHF?
What sector is Siemens Healthineers AG in?
What is SEMHF's market cap?
Does SEMHF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SEMHF for comparison